Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Poxel    POXEL   FR0012432516

POXEL

(POXEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about POXEL
09/16Poxel Reports Financial Results for First Half 2020 and Provides a Corporate ..
AQ
09/15POXEL : 1H 2020 Financial and Corporate Presentation
PU
09/15POXEL : Reports Financial Results for First Half 2020 and Provides a Corporate U..
BU
09/03POXEL : to Host Conference Call for First Half 2020 Financial Results on Septemb..
BU
09/02POXEL : Initiates Phase 2 NASH Trial for PXL065 (DESTINY 1) in Biopsy-Proven Pat..
BU
08/14POXEL : 2nd quarter earnings
CO
08/06POXEL : Corporate Presentation - English
PU
07/30POXEL : Announces Submission of Imeglimin Japanese New Drug Application for the ..
BU
07/21POXEL : Provides Corporate Update and Reports Cash and Revenue for the Second Qu..
BU
07/07POXEL : Corporate Presentation - English
PU
06/25POXEL : Announces Results from June 24, 2020 Ordinary Annual and Extraordinary G..
BU
06/25POXEL : Announces Positive Pharmacokinetic Pharmacodynamic Study Results for PXL..
AQ
06/24POXEL : Announces Positive Pharmacokinetic (PK) / Pharmacodynamic (PD) Study Res..
BU
05/28POXEL : Announces Participation in Upcoming Virtual Investor Conferences
BU
05/26Poxel Successfully Raises EUR17.7 Million in a Capital Increase
AQ
More most relevant news
All news about POXEL
09/16Poxel Reports Financial Results for First Half 2020 and Provides a Corporate ..
AQ
09/15POXEL : 1H 2020 Financial and Corporate Presentation
PU
09/15POXEL : Reports Financial Results for First Half 2020 and Provides a Corporate U..
BU
09/03POXEL : to Host Conference Call for First Half 2020 Financial Results on Septemb..
BU
09/02POXEL : Initiates Phase 2 NASH Trial for PXL065 (DESTINY 1) in Biopsy-Proven Pat..
BU
08/14POXEL : 2nd quarter earnings
CO
08/06POXEL : Corporate Presentation - English
PU
07/30POXEL : Announces Submission of Imeglimin Japanese New Drug Application for the ..
BU
07/21POXEL : Provides Corporate Update and Reports Cash and Revenue for the Second Qu..
BU
07/07POXEL : Corporate Presentation - English
PU
More news
News in other languages on POXEL
09/16Les valeurs à suivre aujourd'hui à la Bourse de Paris Mercredi 16 septembre 2..
09/16La Chine gagne à l'OMC, mais l'Amérique s'en fiche
09/16POXEL : A suivre aujourd'hui
09/16EN DIRECT DES MARCHES : Suez, Europcar, Altice Europe, Rothschild, Kraft Heinz, ..
09/15Les valeurs à suivre demain à la Bourse de Paris Mercredi 16 septembre 2020
09/15POXEL : 46 millions d'euros de trésorerie à la fin du premier semestre
09/15POXEL : publie ses résultats financiers du premier semestre 2020 et dresse un bi..
09/03POXEL : présentera ses résultats semestriels 2020 à l'occasion d'une conférence ..
09/02Le grand écart transatlantique
09/02EN DIRECT DES MARCHES : Pernod Ricard, BioMérieux, Vallourec, BigBen, Clarano..
Press releases
09/16Poxel Reports Financial Results for First Half 2020 and Provides a Corporate ..
AQ
09/15POXEL : 1H 2020 Financial and Corporate Presentation
PU
09/15POXEL : Reports Financial Results for First Half 2020 and Provides a Corporate U..
BU
09/03POXEL : to Host Conference Call for First Half 2020 Financial Results on Septemb..
BU
09/02POXEL : Initiates Phase 2 NASH Trial for PXL065 (DESTINY 1) in Biopsy-Proven Pat..
BU
More press releases